SCHEMBL27666017

SCHEMBL27666017

FC(F)(F)c1ccc(CCCCCN2CCN(c3cccc4n[c]sc34)CC2)cc1

nearest known ligand 0.49

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 3/20 0.49
HTR1A P08908 8/20 0.41
HTR2C P28335 3/20 0.41
DRD2 P14416 4/20 0.40
HTR2A P28223 4/20 0.40
HTR7 P34969 3/20 0.40
HTR6 P50406 2/20 0.40
DRD3 P35462 2/20 0.40
DRD1 P21728 1/20 0.40
DRD5 P21918 1/20 0.40
CYP2C9 P11712 1/20 0.40
DRD4 P21917 2/20 0.39
SLC6A4 P31645 2/20 0.39
SLC6A2 P23975 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27665843 0.85 MAOB (0.38) SIGMAR1CYP2C9SLC6A4SLC6A2
SCHEMBL5012696 0.82 SIGMAR1 (0.46) SIGMAR1HTR1AHTR2CDRD2HTR2A
SCHEMBL5012698 0.82 SIGMAR1 (0.46) SIGMAR1HTR1AHTR2CDRD2HTR2A
SCHEMBL27665886 0.80 SIGMAR1 (0.47) SIGMAR1HTR1AHTR2CDRD2HTR2A
SCHEMBL27645223 0.78 SIGMAR1 (0.54) SIGMAR1HTR1AHTR2CDRD2HTR2A
SCHEMBL27665756 0.77 SIGMAR1 (0.55) SIGMAR1HTR1AHTR2CDRD2HTR2A
SCHEMBL27644453 0.76 SIGMAR1 (0.47) SIGMAR1HTR1AHTR2CDRD2HTR2A
SCHEMBL30671730 0.73 SIGMAR1 (0.73) SIGMAR1HTR1ADRD2HTR2AHTR7
SCHEMBL27645136 0.72 HRH3 (0.47) SIGMAR1HTR1ADRD2HTR2AHTR7
SCHEMBL27645120 0.72 HRH3 (0.47) SIGMAR1HTR1ADRD2HTR2AHTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100497345-C 2, 3-dihydro-6-nitroimidazolo [2,1-b] oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2009-06-10 CN disclosed
CN-1878777-A 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2006-12-13 CN disclosed